| UniProt ID | RIP_HUMAN | |
|---|---|---|
| UniProt AC | Q86UA6 | |
| Protein Name | RPA-interacting protein | |
| Gene Name | RPAIN | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 219 | |
| Subcellular Localization |
Isoform 1: Cytoplasm. Nucleus. Isoform 2: Nucleus, PML body. |
|
| Protein Description | Mediates the import of RPA complex into the nucleus, possibly via some interaction with importin beta. Isoform 2 is sumoylated and mediates the localization of RPA complex into the PML body of the nucleus, thereby participating in RPA function in DNA metabolism.. | |
| Protein Sequence | MAESLRSPRRSLYKLVGSPPWKEAFRQRCLERMRNSRDRLLNRYRQAGSSGPGNSQNSFLVQEVMEEEWNALQSVENCPEDLAQLEELIDMAVLEEIQQELINQEQSIISEYEKSLQFDEKCLSIMLAEWEANPLICPVCTKYNLRITSGVVVCQCGLSIPSHSSELTEQKLRACLEGSINEHSAHCPHTPEFSVTGGTEEKSSLLMSCLACDTWAVIL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MAESLRSPRRS ----CCHHHCCCCHH | 21.39 | 30108239 | |
| 6 | Methylation | --MAESLRSPRRSLY --CCHHHCCCCHHHH | 54.62 | 115368269 | |
| 7 | Phosphorylation | -MAESLRSPRRSLYK -CCHHHCCCCHHHHH | 28.22 | 29255136 | |
| 11 | Phosphorylation | SLRSPRRSLYKLVGS HHCCCCHHHHHHHCC | 37.01 | 26074081 | |
| 13 | Phosphorylation | RSPRRSLYKLVGSPP CCCCHHHHHHHCCCH | 11.97 | - | |
| 14 (in isoform 5) | Ubiquitination | - | 41.83 | 21890473 | |
| 14 (in isoform 1) | Ubiquitination | - | 41.83 | 21890473 | |
| 14 (in isoform 2) | Ubiquitination | - | 41.83 | 21890473 | |
| 14 | Ubiquitination | SPRRSLYKLVGSPPW CCCHHHHHHHCCCHH | 41.83 | 21890473 | |
| 14 (in isoform 3) | Ubiquitination | - | 41.83 | 21890473 | |
| 14 (in isoform 4) | Ubiquitination | - | 41.83 | 21890473 | |
| 14 (in isoform 6) | Ubiquitination | - | 41.83 | 21890473 | |
| 14 (in isoform 7) | Ubiquitination | - | 41.83 | 21890473 | |
| 14 | Ubiquitination | SPRRSLYKLVGSPPW CCCHHHHHHHCCCHH | 41.83 | 21890473 | |
| 18 | Phosphorylation | SLYKLVGSPPWKEAF HHHHHHCCCHHHHHH | 21.95 | 25159151 | |
| 22 | Ubiquitination | LVGSPPWKEAFRQRC HHCCCHHHHHHHHHH | 44.96 | 21890473 | |
| 22 (in isoform 5) | Ubiquitination | - | 44.96 | 21890473 | |
| 22 (in isoform 4) | Ubiquitination | - | 44.96 | 21890473 | |
| 22 (in isoform 3) | Ubiquitination | - | 44.96 | 21890473 | |
| 22 (in isoform 6) | Ubiquitination | - | 44.96 | 21890473 | |
| 22 (in isoform 7) | Ubiquitination | - | 44.96 | 21890473 | |
| 22 (in isoform 2) | Ubiquitination | - | 44.96 | 21890473 | |
| 22 (in isoform 1) | Ubiquitination | - | 44.96 | 21890473 | |
| 22 | Ubiquitination | LVGSPPWKEAFRQRC HHCCCHHHHHHHHHH | 44.96 | 2189047 | |
| 36 | Phosphorylation | CLERMRNSRDRLLNR HHHHHHHHHHHHHHH | 25.78 | 29978859 | |
| 112 (in isoform 8) | Phosphorylation | - | 23.13 | 27642862 | |
| 114 | Ubiquitination | SIISEYEKSLQFDEK HHHHHHHHHHCCCHH | 56.41 | - | |
| 121 | Sumoylation | KSLQFDEKCLSIMLA HHHCCCHHHHHHHHH | 42.17 | 16135809 | |
| 148 | Phosphorylation | TKYNLRITSGVVVCQ CCCCCEECCCEEEEE | 17.00 | 21406692 | |
| 149 | Phosphorylation | KYNLRITSGVVVCQC CCCCEECCCEEEEEC | 27.50 | 21406692 | |
| 159 | Phosphorylation | VVCQCGLSIPSHSSE EEEECCCCCCCCCHH | 20.10 | 21406692 | |
| 162 | Phosphorylation | QCGLSIPSHSSELTE ECCCCCCCCCHHHHH | 34.04 | 21406692 | |
| 164 | Phosphorylation | GLSIPSHSSELTEQK CCCCCCCCHHHHHHH | 29.82 | 21406692 | |
| 165 | Phosphorylation | LSIPSHSSELTEQKL CCCCCCCHHHHHHHH | 31.07 | 21406692 | |
| 168 | Phosphorylation | PSHSSELTEQKLRAC CCCCHHHHHHHHHHH | 32.11 | 21406692 | |
| 171 | Ubiquitination | SSELTEQKLRACLEG CHHHHHHHHHHHHHC | 33.44 | - | |
| 190 | Phosphorylation | HSAHCPHTPEFSVTG CCCCCCCCCCEEECC | 15.06 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RIP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 103 | K | Sumoylation |
| 16135809 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RIP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RFA1_HUMAN | RPA1 | physical | 26186194 | |
| RFA2_HUMAN | RPA2 | physical | 26186194 | |
| UBR7_HUMAN | UBR7 | physical | 26186194 | |
| RFA1_HUMAN | RPA1 | physical | 28514442 | |
| UBR7_HUMAN | UBR7 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |